STAAR Surgical Generates $464,000 in Cash from Operations During Thi... (/AppData/Local/Microsoft/Windows/Local S...)

STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter

Date:11/2/2009

/AppData/Local/Microsoft/Windows/Local Settings/dandrews/Loca">www.staar.com.

Safe Harbor

All statements in this press release that are not statements of historical fact are forward-looking statements, including statements about any of the following: projections of earnings, revenue, sales, cash or any other financial items; the plans, strategies, and objectives of management for future operations or prospects for achieving such plans; future sale; prospects for approval of the Visian Toric ICL supplemental premarket approval application, or any other future approval by the FDA or other regulatory agencies; our future performance; statements of belief; and any statements of assumptions underlying any of the foregoing.

These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. The risks and uncertainties include our limited capital resources and limited access to financing, the fact that our public accounting firm has expressed doubt about our ability to continue as a going concern in their opinion on our financial statements, the broad discretion of the FDA in approving any medical device and the inherent uncertainty that new devices will be approved, the likelihood of administrative delays, the need in certain future FDA submissions to satisfy additional and potentially costly requirements such as third party audits, the cost of defending pending litigation and satisfying judgment in the event of an adverse ruling, for which we have taken no reserve, the fact that insurance covers only a portion of the cost of pending litigation, cannot cover punitive damages, and may not cover compensatory damages in the event of an adverse ruling; the negative effect of the global recession on sales of products, especi
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Related medicine technology :

1. STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
2. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
3. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
4. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
5. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
6. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
7. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
8. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
9. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
10. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
11. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery

Post Your Comments:

(Date:12/15/2009)... Dec. 15 Cumberland Pharmaceuticals Inc. ... announced new top-line results for a patient preference ... Solution, a prescription laxative packaged as a crystalline ... ,, Kristalose is the only prescription-strength laxative available ... 50 patients with a recent diagnosis of chronic ...

(Date:12/15/2009)... -- Today,s New York Times ... Drugs Spurs Division," illustrates an internal renal community ... continuing to be deprived of their life-saving immunosuppressive ... ,, As Congress is poised to approve this ... of transplant kidney recipients, behind-the-scenes debate continues within ...

(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, Surgical ... the U.S. and its International Trade ... http://www.reportlinker.com/p0167745/Surgical-and-Medical-Instrument-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, The just released ... Instrument Manufacturing Industry report is the ...

Breaking Medicine Technology:Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 2 Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 3 AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate 2 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8 Many Women Miscalculate Time to Full Term Birth 61852 1 Many Women Miscalculate Time to Full Term Birth 61852 2 Many Women Miscalculate Time to Full Term Birth 61852 3 Many Women Miscalculate Time to Full Term Birth 61852 4 New Breast Cancer Recommendation May Cost Lives While Saving Money 61848 1 New Breast Cancer Recommendation May Cost Lives While Saving Money 61848 2 New Breast Cancer Recommendation May Cost Lives While Saving Money 61848 3 California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pai 61844 1 California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pai 61844 2 California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pai 61844 3 California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pai 61844 4

[0] Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study [0] AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate [0] Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]

... Dec. 18 Epeius Biotechnologies,Corporation announced today ... of,Product Registration for Rexin-G(R) from the Philippine ... commercialization of its lead product as a ... of intractable cancers.,Developed as a tumor-targeted anticancer ...

... Scimitar Equity Research, Inc. issues a,review on Nventa ... and Vaccine Candidate for the Treatment of,Diseases Caused ... is,available on Scimitar,s website: http://www.scimitarequity.com ., ... therapeutics for the treatment of viral,infections and cancer, ...

Other Medicine Technology:ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer 2 ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer 3 Initiation of Coverage Informational Review Issued by Scimitar Equity Research 2

ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer Initiation of Coverage Informational Review Issued by Scimitar Equity Research

(Date:12/15/2009)... ANN ARBOR, Mich. A new study links chronic ... cells that act as sentinels to activate the body,s ... Veterans Affairs research adds to growing awareness of the ... disease that affects more than 12 million Americans with ... Understanding immune factors is key if doctors are to ...

(Date:12/15/2009)... United Nations Foundation has led the fight against malaria, and ... 2009 that the global strategies for ending malaria deaths are working,” ... United Nations Foundation , ... Washington, D.C. (Vocus) December ... Foundation has led the fight against malaria, and I am ...

(Date:12/15/2009)... changes increases risk in teens, study suggests , , TUESDAY, ... or obese increases the risk of obstructive sleep apnea, ... for younger children, Australian researchers have found. , In ... to 18, who were referred for evaluation of snoring ... among those aged 12 and older the risk of ...

(Date:12/15/2009)... RPS Worldwide Launches their Affiliate Program, a new employment opportunity for ... the simplest and easiest business opportunities in America today. , ... ... one of the nation,s most successful collection agencies, is spreading holiday ... after the season,s end. RPS has created an opportunity for ...

(Date:12/15/2009)... decide benefits of imaging outweigh the risks , , TUESDAY, ... a serious risk to people with heart pacemakers, researchers ... pacemakers to a simulated MRI magnetic field and then ... the pacemaker lead, where it would touch the interior ... magnetic pulses caused certain pacemakers to deliver a drastically ...

Breaking Medicine News(10 mins):Health News:Immune cell activity linked to worsening COPD 2 Health News:Immune cell activity linked to worsening COPD 3 Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2 Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2 Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 2 Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 3 Health News:Patients With Pacemakers Should Avoid MRI Scans 2

[1] Immune cell activity linked to worsening COPD [0] Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 [0] Puberty May Trigger Sleep Apnea in Overweight Kids [0] RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away [0] Patients With Pacemakers Should Avoid MRI Scans

... intervention is more effective than short-term vitamin E capsule therapy ... in the management of children with NAFLD. , ... Liang, is described in a research article to be published ... , NAFLD is likely to reach epidemic proportions in children ...

... Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) today announced ... NASDAQ Global Market closes on Wednesday, May,7, 2008. That ... and Robert E. Hoffman, Arena,s Vice President, Finance,and Chief ... p.m.,Eastern Time (2:00 p.m. Pacific Time) to discuss the ...

... Kitchen 6 Weeks to Summer(SM) to Help You Look and Feel ... ... Are you working towards a,healthier lifestyle? Looking for new recipes or ... Weeks to,Summer(SM) is designed to help you stay on track with your ...

... C. diff-associated disease (CDAD), otherwise known as severe ... diff) pathogen, has been the subject of heightened concern ... this month by the federal Agency for Healthcare Research ... fatal diarrheal infections in U.S. hospitals between 2000 and ...

... up 54.1%; Adjusted EPS down 9.9% Company Lowers ... , ... Glance, -- Reported EPS up 54.1 percent at $1.71 -- Adjusted ... repurchase program -- R.J. Reynolds continues to build total growth-brand share ...

... PARK, Fla., April 30 Nihon LocalSoft, ... for the purpose of supporting US,Medical Device ... support entering the Japanese market, recently helped ... translations,labeling, and localized embedded text for their ...

How to manage Chinese obese children with non-alcoholic fatty liver disease?Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008 Keep Healthy Goals on Track This Summer Report raises C. diff concerns; yeast-based probiotic shown to help significantly reduce recurrence RAI CEO: 'Returning Value in a Challenging Time'Nihon LocalSoft Designs New Japanese Software for IRadimed Corporation's Award-Winning MRidium MRI Infusion System

Width 3 (76 mm), length 6 3/4 (171 mm). Pattie Tray attaches to long or short arm....

Kit is supplied with four secondary bars. Secondary bars attach to primary bar. Length 12 (305 mm)....

TEW serrated micro-retractor blade set....

Mini-Vise....

Medicine Products:

Greenberg Pattie Tray Greenberg Secondary Bar TEW Serrated Micro-Retractor Blade Set Mini-Vise

STAAR Surgical Generates $464,000 in Cash from Operations During Thi...(/AppData/Local/Microsoft/Windows/Local S...),Health